Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Lin, Shaojun ^a   Lu, Jiade J ^b   Han, Lu ^a   Chen, Qisong ^a   Pan, Jianji ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGE; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG FATALITY; FEMALE; FOLLOW UP; HUMAN; INFECTION; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LOCAL METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NECROSIS; OVERALL SURVIVAL; PERSONAL EXPERIENCE; PROGNOSIS; PROGRESSION FREE SURVIVAL; REGIONAL METASTASIS; SKIN EXFOLIATION; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR CLASSIFICATION; XEROSTOMIA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; RADIOTHERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77949442563     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-39     Document Type: Article

References (21)

1. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998, 16(4):1310-1317.
2. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005, 23(27):6730-6738. 10.1200/JCO.2005.16.790, 16170180.
3. Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002, 20(8):2038-2044. 10.1200/JCO.2002.08.149, 11956263.
4. Cheng SH, Jian JJ, Tsai SY, et al. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2000, 48(5):1323-30.
5. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006, 64(1):47-56.
6. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 2004, 101(7):1584-1593. 10.1002/cncr.20552, 15378492.
7. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002, 53(1):12-22.
8. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004, 60(5):1440-1450.
9. Tham IWK, Hee SW, Yeo RMC, et al. Treatment of nasopharyngeal carcinoma using intensity modulated radiotherapy - the National Cancer Center Singapore experience. Int J Radiat Oncol Biol Phys 2009,
10. Lin S, Pan J, Han L, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: Report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 2009,
11. Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual. 1997, Philadelphia: Lippincott-Raven, 5.
12. Grégoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003, 69(3):227-36. 10.1016/j.radonc.2003.09.011, 14644481.
13. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000, 48(2):329-337.
14. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31(5):1341-1346.
15. National Comprehensive Cancer Network Head and Neck Cancers Version 2.2008. Accessed on April 16, 2009., National Comprehensive Cancer Network., http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf
16. Cooper JS, Lee H, Torrey M, et al. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys 2000, 47(4):861-6.
17. Ma J, Mai HQ, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal crcinoma. J Clin Oncol 2001, 19(5):1350-7.
18. Sanguineti G, Geara F, Garden A, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997, 37(5):985-996.
19. Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985, 11(8):1455-1459.
20. Bedwinek JM, Perez CA, Keys DJ. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer 1980, 45(11):2725-2729. 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1, 7379006.
21. Cooper JS. Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 2000, 48(5):1277-2000.